POT1 and liver cancer: In addition, MEG3 promotes the interaction between P53 and HULC, which inhibits the binding of telomere length maintenance complex POT1-Exo1-TRF2-SNM1B to telomeric DNA, and finally inhibits the length of telomeres in human liver cancer stem cells.